Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) Antibodies:
anti-Mouse (Murine) Antibodies:
Go to our pre-filtered search.
Hamster Polyclonal NPY1R Primary Antibody for IEM, ICC - ABIN617932
Hiruma, Saito, Kusakabe, Takenaka, Kawakami: Neuropeptide Y inhibits axonal transport of particles in neurites of cultured adult mouse dorsal root ganglion cells. in The Journal of physiology 2002
Show all 12 Pubmed References
Human Polyclonal NPY1R Primary Antibody for IHC (p), ELISA - ABIN2475861
Wheatley: The stress profile. in The British journal of psychiatry : the journal of mental science 1991
Show all 2 Pubmed References
genetic variation in NPY (show NPY Antibodies) and NPY2R (show NPY2R Antibodies) is at low frequency and thus does not make a major contribution to the obese phenotype in the general population
Genetic risk score (GRSNPY) analysis found twelve significant (P<0.05) serum NPY (show NPY Antibodies) concentration related SNPs among alpha7 nicotinic acetylcholine receptor gene CHRNA7 (show CHRNA7 Antibodies), insulin receptor (show INSR Antibodies) gene INSR (show INSR Antibodies), leptin receptor (show LEPR Antibodies) gene LEPR (show LEPR Antibodies), glucocorticoid receptor (GR (show NR3C1 Antibodies)) gene NR3C1 (show NR3C1 Antibodies), and NPY (show NPY Antibodies) gene. However, after permutation test of gene score the predictive value of GRSNPY remained non-significant (P=0.078). CONCLUSIONS: Serum NPY (show NPY Antibodies) level ...
In obese males, the rs164147 polymorphism of the NPY (show NPY Antibodies) gene is associated with leptin (show LEP Antibodies), insulin (show INS Antibodies) level, HOMA-IR, and an increased risk of MetS (show ETV3 Antibodies) and its related phenotypes, such as central obesity and hyperglycemia.
Both structural (+1128T/C) and promoter polymorphisms (-399 T/C) of Neuropeptide Y (show NPY Antibodies) are strongly associated with type-II diabetes susceptibility in Gujarat population which at least in part, may result in higher levels of Neuropeptide Y (show NPY Antibodies) thereby suggesting its crucial role in type-II diabetes susceptibility.
Hypermethylation of WIF1 (WNT inhibitory factor 1 (show WIF1 Antibodies)) and NPY (neuropeptide Y (show NPY Antibodies)) genes was significantly higher in tumor tissue compared to normal tissue, independently of tumor stage.
Our results provided clinical evidences for NPY (show NPY Antibodies) participating in the bone healing process in a nonhypothalamic manner, most probably by directly promoting osteogenesis of mesenchymal stem cells.
In conclusion, the obtained results demonstrate the probable role of NPY (show NPY Antibodies) SNPs in susceptibility to multiple sclerosis within the Iranian population.
Neuropeptide Y (show NPY Antibodies) is the best dipeptidyl peptidase 4 (DPP4 (show DPP4 Antibodies))-substrate in blood, being truncated by soluble and membrane DPP4 (show DPP4 Antibodies), respectively. The decline of soluble DPP4 (show DPP4 Antibodies) in acute depression could be reversed upon anti-depressive treatment.
study implicates NPY (show NPY Antibodies) as a potential target in antihypertensive therapies for preeclampsia patients
NPY is efficiently cleaved by FAP indicating a potential function for FAP in neuropeptide regulation within liver and cancer biology.
This gene encodes a neuropeptide that is widely expressed in the central nervous system and influences many physiological processes, including cortical excitability, stress response, food intake, circadian rhythms, and cardiovascular function. The neuropeptide functions through G protein-coupled receptors to inhibit adenylyl cyclase, activate mitogen-activated protein kinase (MAPK), regulate intracellular calcium levels, and activate potassium channels. A polymorphism in this gene resulting in a change of leucine 7 to proline in the signal peptide is associated with elevated cholesterol levels, higher alcohol consumption, and may be a risk factor for various metabolic and cardiovascular diseases.
, pro-neuropeptide Y